Grigoris Gerotziafas Shares The APICAT Study Post Hoc Analysis
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn:
”APICAT study post hoc analysis, Just published: During extended treatment for cancer-associated VTE, four predictors of clinically relevant bleeding were identified in the overall population of patients treated with apixaban, with no evidence of interaction with the dosing regimen.
Anaemia and/or thrombocytopenia, age 75 years or older, pulmonary embolism as the index event, and male sex were significantly associated with an increased risk of clinically relevant bleeding.
Isabelle Mahé 1 , Céline Chapelle 2 , Philippe Girard 3 , Marc Carrier 4 , Luis Jara Palomares 5 , Charles-Marc Samama 6 , Hélène Helfer 7 , Grigoris Gerotziafas 8 , Silvy Laporte 9 , Eric Vicaut 10 , Patrick Mismetti 11 ; API-CAT Study Group; API-CAT Investigators. Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial.
Lancet Haematol. 2026 Jan;13(1):e41-e48.”
Read the full article here.
Article: Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Authors: Isabelle Mahé, Céline Chapelle, Philippe Girard, Marc Carrier, Luis Jara Palomares, Charles-Marc Samama
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 3, 2026, 17:12Matteo Foschi: Cancer Worsens Prognosis after Breakthrough Ischemic Stroke Despite Oral Anticoagulation
-
Mar 3, 2026, 17:04Shiny K Kajal: Therapeutic Apheresis Is Redefining the Clinical Scope of Transfusion Medicine
-
Mar 3, 2026, 16:58Non-Carrier Mothers of Inv22 Hemophilia A Patients Frequently Harbor Additional F8 Gene Rearrangements – JTH
-
Mar 3, 2026, 16:53Valentina Rossi: Addressing Inflammation and Immune Mechanisms in Cardiomyopathy Management
-
Mar 3, 2026, 16:45Emmanuel J Favaloro: New Publication on Artificial Intelligence in Thrombosis and Hemostasis in CCLM
-
Mar 3, 2026, 16:32Scott E. Smith: Why Hematology Research Is the True Leader of all Medical Disciplines
-
Mar 3, 2026, 16:21Tareq Abadl: Why HIV Antibodies Stay Positive Even When Viral Load Is Zero?
-
Mar 3, 2026, 16:12Mark Crowther Congratulates Mary Cushman on Her Appointment as ISTH President
-
Mar 3, 2026, 15:42Cheng-Hock Toh։ The Unrecognised Central Role of Hematology in Healthcare Design